GENinCode (LON:GENI) Stock Price Up 24.3% – What’s Next?

Shares of GENinCode Plc (LON:GENIGet Free Report) rose 24.3% during mid-day trading on Tuesday . The stock traded as high as GBX 4.98 ($0.06) and last traded at GBX 4.97 ($0.06). Approximately 420,112 shares were traded during trading, a decline of 59% from the average daily volume of 1,017,303 shares. The stock had previously closed at GBX 4 ($0.05).

GENinCode Stock Performance

The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89. The company has a market capitalization of £8.80 million, a PE ratio of -99.44 and a beta of 0.66. The stock has a 50-day simple moving average of GBX 3.85 and a 200 day simple moving average of GBX 4.97.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Stories

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.